Case File №
#VI-2026-0192
Zztai Peptide
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
40 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | C Okay | 11 | 7.2 | 5.0 | 9.6 | 9 Jun 2025 |
| Tirzepatide | C Okay | 19 | 6.4 | 4.1 | 9.8 | 9 Jun 2025 |
| ACE-031 | C Fair | 3 | 5.7 | 4.2 | 7.7 | 21 May 2026 |
| Adamax | C Fair | 2 | 7.6 | 7.4 | 7.7 | 21 May 2026 |
| AICAR Oral | X N/A | 1 | 4.4 | 4.4 | 4.4 | 7 May 2025 |
| Anavar (Oxandrolone) | C Fair | 3 | 5.9 | 5.4 | 6.3 | 17 May 2026 |
| Benzaldehyde CAS 100-52-7 | X N/A | 1 | 6.2 | 6.2 | 6.2 | 6 May 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 7.1 | 7.1 | 7.1 | 14 Jan 2025 |
| Cartalax | X N/A | 1 | 4.0 | 3.0 | 3.0 | 11 Jun 2025 |
| Cerebrolysin | C Fair | 2 | 6.4 | 6.3 | 6.5 | 26 Jan 2026 |
| CJC-1295 With DAC | X N/A | 1 | 6.5 | 6.5 | 6.5 | 9 Jun 2025 |
| Clenbuterol | C Fair | 3 | 7.2 | 6.8 | 7.5 | 24 May 2026 |
| DHB (1-Test Cyp) | C Fair | 2 | 5.4 | 4.6 | 6.2 | 17 May 2026 |
| Drostanolone Propionate (Mast P) Raw | X N/A | 1 | 7.2 | 7.2 | 7.2 | 27 Feb 2025 |
| EPO | X N/A | 1 | 4.0 | 3.2 | 3.2 | 9 Jun 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | C Fair | 2 | 6.5 | 4.6 | 8.4 | 17 May 2026 |
| Hyaluronic acid | X N/A | 1 | 7.2 | 7.2 | 7.2 | 24 Apr 2025 |
| IGF-1 LR3 | C Fair | 3 | 4.9 | 2.2 | 6.5 | 24 May 2026 |
| Lipo-C 120mg | X N/A | 1 | 6.3 | 6.3 | 6.3 | 17 Dec 2024 |
| Liraglutide | C Fair | 2 | 7.0 | 6.4 | 7.5 | 20 May 2026 |
| Livagen | C Fair | 3 | 5.5 | 3.9 | 6.4 | 21 May 2026 |
| Minoxidil Oral | X N/A | 1 | 4.5 | 4.5 | 4.5 | 9 Jun 2025 |
| MK-677 (Ibutamoren) Raw | X N/A | 1 | 7.9 | 7.9 | 7.9 | 27 Feb 2025 |
| MOTS-C | X N/A | 1 | 6.0 | 6.0 | 6.0 | 25 Apr 2025 |
| NAD+ | C Fair | 2 | 7.1 | 6.9 | 7.3 | 24 May 2026 |
| Orforglipron | C Fair | 2 | 8.1 | 8.0 | 8.1 | 21 May 2026 |
| Oxytocin Acetate | X N/A | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 |
| P21 | X N/A | 1 | 8.1 | 8.1 | 8.1 | 11 Jun 2025 |
| PTD-DBM | C Fair | 3 | 7.9 | 6.9 | 9.8 | 17 May 2026 |
| RAD-140 (Testolone) Raw | X N/A | 1 | 9.6 | 9.6 | 9.6 | 2 Apr 2025 |
| Retatrutide 30mg Pen Kit | C Fair | 2 | 6.1 | 5.3 | 6.9 | 25 May 2026 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 5.2 | 5.2 | 5.2 | 11 Jun 2025 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | X N/A | 1 | 6.2 | 6.2 | 6.2 | 13 Feb 2025 |
| Telmisartan | C Fair | 2 | 6.9 | 6.1 | 7.7 | 25 May 2026 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | C Fair | 3 | 7.3 | 5.4 | 10.0 | 20 May 2026 |
| Test Suspension | X N/A | 1 | 6.6 | 6.6 | 6.6 | 16 Mar 2025 |
| Tren Hex | C Fair | 3 | 7.3 | 5.7 | 8.3 | 21 May 2026 |
| TrenMix 200 | C Fair | 3 | 5.7 | 5.1 | 6.5 | 21 May 2026 |
| Vilon | X N/A | 1 | 7.2 | 7.2 | 7.2 | 11 Jun 2025 |
| Vitamin B12 10mg/ml | X N/A | 1 | 9.3 | 9.3 | 9.3 | 3 Jun 2025 |
Exhibit II
Evidence Log
72 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 4.7 C | 5mg | 5.1mg | +1.6% | 98.46% | ar6lhq | Lab A | Public |
| 25 May 2026 | Liraglutide | 6.5 A | 2mg | 1.8mg | -11.4% | 98.81% | zetru4 | Lab C | Public |
| 25 May 2026 | Tren Hex | 7.4 A | 100mg/ml | 90.8mg/ml | -9.2% | 96.09% | z5ckch | Lab A | Public |
| 24 May 2026 | Hyaluronic acid | 7.3 A | 5mg | 5.4mg | +8.7% | 98.28% | 11esys | Lab E | Public |
| 24 May 2026 | Lipo-C 120mg | 6.9 A | 300mg/ml | 287.3mg/ml | -4.2% | 97.20% | ml1h8c | Lab C | Public |
| 24 May 2026 | Livagen | 6.7 A | 10mg | 10.2mg | +2.5% | 99.30% | sgyy75 | Lab E | Community |
| 24 May 2026 | NAD+ | 7.1 A | 2mg | 1.7mg | -13.1% | 99.77% | 9iccyd | Lab E | Community |
| 24 May 2026 | Adamax | 6.1 A | 50mg | 53.3mg | +6.6% | 98.38% | f68tlk | Lab A | Public |
| 24 May 2026 | NAD+ | 7.3 A | 10mg | 11.1mg | +10.5% | 99.18% | 1p0c5h | Lab A | Community |
| 24 May 2026 | IGF-1 LR3 | 5.2 B | 20mg | 23.4mg | +16.9% | 99.69% | 3umlad | Lab D | Community |
| 24 May 2026 | PTD-DBM | 9.6 A | 10mg | 10.1mg | +1.1% | 96.88% | 8cs076 | Lab G | Community |
| 24 May 2026 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 5.5 B | 25mg | 25.1mg | +0.2% | 99.87% | 7c106b | Lab C | Community |
| 24 May 2026 | DHB (1-Test Cyp) | 4.6 C | 250mg/ml | 214.6mg/ml | -14.2% | 99.03% | jorv2a | Lab B | Public |
| 24 May 2026 | MK-677 (Ibutamoren) Raw | 6.7 A | 500g | 556.6g | +11.3% | 97.03% | vojn6r | Lab F | Community |
| 24 May 2026 | RAD-140 (Testolone) Raw | 10.0 A | 1g | 1.2g | +21.7% | 96.44% | skn92y | Lab B | Public |
| 24 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 7.4 A | 5mg | 4.8mg | -4.2% | 99.15% | g4pkcp | Lab D | Community |
| 24 May 2026 | Vitamin B12 10mg/ml | 10.0 A | 300mg/ml | 311.2mg/ml | +3.7% | 96.62% | rmc4vl | Lab A | Public |
| 24 May 2026 | IGF-1 LR3 | 6.6 A | 2mg | 1.8mg | -10.6% | 96.05% | jycrei | Lab A | Community |
| 24 May 2026 | Minoxidil Oral | 4.0 C | 100mg | 120.4mg | +20.4% | 99.03% | iptm43 | Lab A | Public |
| 24 May 2026 | Telmisartan | 7.7 A | 25mg | 21.4mg | -14.6% | 99.44% | 9li5fg | Lab E | Public |
| 24 May 2026 | Tren Hex | 7.6 A | 300mg/ml | 357.8mg/ml | +19.3% | 95.73% | j5slfn | Lab G | Public |
| 23 May 2026 | IGF-1 LR3 | 6.4 A | 30mg | 30.0mg | -0.1% | 95.03% | ehm0qk | Lab F | Public |
| 22 May 2026 | Retatrutide | 9.6 A | 30mg | 30.2mg | +0.7% | 99.74% | 12/9/25-SS67 | Lab E | Public |
| 21 May 2026 | Cerebrolysin | 5.9 B | 2mg | 2.1mg | +5.3% | 97.14% | n55zx0 | Lab C | Community |
| 21 May 2026 | Clenbuterol | 5.3 B | 25mg | 25.4mg | +1.7% | 98.73% | xpfx62 | Lab G | Public |
| 21 May 2026 | DHB (1-Test Cyp) | 6.9 A | 200mg/ml | 238.3mg/ml | +19.1% | 95.73% | ok1aj5 | Lab F | Public |
| 21 May 2026 | Telmisartan | 6.5 A | 10mg | 9.3mg | -6.7% | 97.61% | 8iblj1 | Lab D | Community |
| 20 May 2026 | Retatrutide | 6.0 B | 5mg | 4.6mg | -8.0% | 99.50% | (no batch ID) | Lab G | Public |
| 20 May 2026 | EPO | 4.0 C | 50mg | 59.4mg | +18.8% | 96.97% | dmt713 | Lab F | Community |
| 20 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 8.4 A | 15mg | 13.9mg | -7.3% | 95.90% | cyatza | Lab F | Public |
| 19 May 2026 | Cerebrolysin | 6.5 A | 50mg | 56.3mg | +12.5% | 96.43% | 60kq8k | Lab G | Community |
| 19 May 2026 | Clenbuterol | 7.2 A | 100mg | 124.1mg | +24.1% | 96.63% | ida8wu | Lab A | Public |
| 19 May 2026 | Livagen | 4.4 C | 20mg | 24.0mg | +20.1% | 95.24% | hlvkj0 | Lab A | Public |
| 19 May 2026 | Orforglipron | 6.9 A | 100mg | 87.6mg | -12.4% | 95.32% | f9b77l | Lab A | Public |
| 17 May 2026 | Cartalax | 4.0 C | 5mg | 5.7mg | +14.9% | 99.68% | u50vzd | Lab G | Public |
| 17 May 2026 | MOTS-C | 4.9 C | 10mg | 9.4mg | -6.0% | 96.05% | xcg3at | Lab B | Public |
| 17 May 2026 | Tren Hex | 9.3 A | 250mg/ml | 286.3mg/ml | +14.5% | 99.43% | s9amwh | Lab E | Public |
| 29 Jan 2026 | AICAR Oral | 4.0 C | 100mg | 117.5mg | +17.5% | 96.41% | pv24l1 | Lab G | Public |
| 29 Jan 2026 | Anavar (Oxandrolone) | 7.1 A | 50mg | 54.3mg | +8.7% | 98.30% | ssvxdf | Lab F | Public |
| 29 Jan 2026 | Oxytocin Acetate | 7.4 A | 50mg | 61.8mg | +23.6% | 95.64% | ye4qw1 | Lab E | Public |
| 29 Jan 2026 | Retatrutide 30mg Pen Kit | 4.8 C | 2mg | 2.5mg | +23.5% | 97.55% | 8p5gk2 | Lab E | Public |
| 26 Jan 2026 | Anavar (Oxandrolone) | 7.1 A | 100mg | 92.2mg | -7.8% | 99.32% | e4msng | Lab E | Public |
| 19 Jan 2026 | Selank 10mg + Semax 10mg Blend | 4.8 C | 10mg | 10.3mg | +3.0% | 96.17% | oesdgh | Lab A | Public |
| 19 Jan 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 7.6 A | 15mg | 15.9mg | +6.1% | 97.14% | 8e8409 | Lab B | Public |
| 9 Jan 2026 | Tirzepatide | 8.4 A | 10mg | 8.96mg | -10.4% | 99.95% | jun 2,2025 | Lab E | Public |
| 9 Jan 2026 | ACE-031 | 5.6 B | 15mg | 15.1mg | +0.9% | 97.53% | 3609ih | Lab E | Public |
| 7 Jan 2026 | Tirzepatide | 7.5 A | 10mg | 10.5mg | +5.0% | 99.70% | (no batch ID) | Lab G | Public |
| 7 Jan 2026 | Retatrutide | 7.5 A | 10mg | 9.7mg | -3.0% | 99.70% | (no batch ID) | Lab G | Public |
| 7 Jan 2026 | Adamax | 8.8 A | 30mg | 26.0mg | -13.2% | 96.81% | xuory6 | Lab G | Public |
| 7 Jan 2026 | Clenbuterol | 7.7 A | 50mg | 51.6mg | +3.1% | 98.28% | 5fivje | Lab E | Community |
| 7 Jan 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 9.6 A | 5mg | 6.1mg | +22.8% | 97.27% | 95ffuv | Lab G | Public |
| 6 Jan 2026 | Retatrutide 30mg Pen Kit | 4.4 C | 2mg | 2.2mg | +10.4% | 97.15% | hahmu1 | Lab G | Public |
| 6 Jan 2026 | Vilon | 7.2 A | 10mg | 12.1mg | +20.8% | 99.36% | q07nk3 | Lab A | Community |
| 1 Jan 2026 | Tirzepatide | 7.6 A | 15mg | 15.8mg | +5.3% | 99.80% | (no batch ID) | Lab G | Public |
| 29 Dec 2025 | Benzaldehyde CAS 100-52-7 | 4.6 C | 5g | 5.6g | +12.0% | 97.65% | 085xop | Lab F | Public |
| 29 Dec 2025 | TrenMix 200 | 5.4 B | 250mg/ml | 299.6mg/ml | +19.8% | 96.15% | temuqm | Lab C | Public |
| 16 Dec 2025 | Retatrutide | 9.5 A | 10mg | 10.3mg | +3.0% | 99.70% | June 5, 2025 | Lab G | Public |
| 12 Dec 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.2 A | 10mg | 8.5mg | -14.8% | 99.17% | ig7q1u | Lab C | Public |
| 23 Nov 2025 | Anavar (Oxandrolone) | 6.8 A | 10mg | 12.4mg | +23.8% | 96.18% | lc0rcr | Lab F | Public |
| 23 Nov 2025 | Drostanolone Propionate (Mast P) Raw | 6.8 A | 5g | 4.9g | -2.9% | 95.45% | h1vzp7 | Lab E | Public |
| 23 Nov 2025 | Liraglutide | 5.1 B | 20mg | 24.8mg | +23.8% | 98.85% | wukauk | Lab G | Community |
| 17 Nov 2025 | ACE-031 | 4.8 C | 5mg | 4.4mg | -11.3% | 95.49% | 96661g | Lab C | Community |
| 17 Nov 2025 | Orforglipron | 9.4 A | 50mg | 42.6mg | -14.7% | 95.21% | 94ncd5 | Lab C | Public |
| 17 Nov 2025 | TrenMix 200 | 5.2 B | 300mg/ml | 372.9mg/ml | +24.3% | 96.75% | 25lu44 | Lab G | Community |
| 14 Nov 2025 | P21 | 8.9 A | 15mg | 16.8mg | +11.7% | 97.76% | vn3e5a | Lab E | Community |
| 5 Nov 2025 | PTD-DBM | 7.0 A | 10mg | 12.0mg | +20.0% | 97.41% | 4n282z | Lab F | Public |
| 4 Nov 2025 | Test Suspension | 6.5 A | 300mg/ml | 280.9mg/ml | -6.4% | 97.49% | 4wlmz1 | Lab F | Public |
| 17 Oct 2025 | ACE-031 | 5.8 B | 10mg | 10.9mg | +9.0% | 96.51% | 6jrwu1 | Lab A | Public |
| 9 Oct 2025 | Livagen | 4.4 C | 20mg | 20.7mg | +3.4% | 95.24% | m1ou4x | Lab A | Public |
| 3 Oct 2025 | CJC-1295 With DAC | 6.9 A | 30mg | 29.3mg | -2.2% | 96.45% | ikwr26 | Lab E | Community |
| 3 Oct 2025 | PTD-DBM | 6.2 A | 2mg | 1.9mg | -3.0% | 98.92% | 5wqjta | Lab D | Community |
| 3 Oct 2025 | TrenMix 200 | 7.5 A | 300mg/ml | 352.6mg/ml | +17.5% | 96.98% | vknfxv | Lab F | Public |
— END OF EVIDENCE LOG —